Amphotericin B Formulations – The Possibility of Generic Competition

Publisher： Bentham Science Publishers

E-ISSN： 2211-7393|1|4|250-258

ISSN： 2211-7385

Source： Pharmaceutical Nanotechnology, Vol.1, Iss.4, 2013-11, pp. : 250-258

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The lipid formulations of amphotericin B

By Herbrecht Raoul   Natarajan-Amé Shanti   Nivoix Yasmine   Letscher-Bru Valérie  

Expert Opinion on Pharmacotherapy, Vol. 4, Iss. 8, 2003-08 ,pp. : 1277-1287

Informa Healthcare

Access to resources Recommend Favorite

Amphotericin B formulations in invasive aspergillosis

By  

Inpharma, Vol. 1, Iss. 1355, 2002-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite

Fatal Mix-up in amphotericin B formulations

By  

Inpharma, Vol. 1, Iss. 1605, 2007-01 ,pp. : 21-21

Adis International

Access to resources Recommend Favorite

New Formulations and Derivatives of Amphotericin B for Treatment of Leishmaniasis

By  

Mini Reviews in Medicinal Chemistry, Vol. 6, Iss. 2, 2006-02 ,pp. : 153-162

Bentham Science Publishers

Access to resources Recommend Favorite

Determination of the Relative Toxicity of Amphotericin B Formulations: A Red Blood Cell Potassium Release Assay

By Jensen G. M.   Skenes C. R.   Bunch T. H.   Weissman C. A.   Amirghahari N.   Satorius A.   Moynihan K. L.   Eley C. G. S.  

Drug Delivery, Vol. 6, Iss. 2, 1999-04 ,pp. : 81-88

Informa Healthcare

Access to resources Recommend Favorite